首页 | 本学科首页   官方微博 | 高级检索  
检索        

DNA芯片检测肝组织及血清中乙型肝炎病毒DNA的临床研究
引用本文:赵伟,万建民,刘伟,张林,刘全俊,周镇先,刘新珏.DNA芯片检测肝组织及血清中乙型肝炎病毒DNA的临床研究[J].中华检验医学杂志,2003,26(2):79-82.
作者姓名:赵伟  万建民  刘伟  张林  刘全俊  周镇先  刘新珏
作者单位:1. 210003,南京农业大学遗传研究所
2. 东南大学医学院附属南京市第二医院病理科
3. 东南大学分子与生物电子国家重点实验室
基金项目:江苏省科技厅江苏省卫生厅重点资助项目(BS2 0 0 0 0 2 8)
摘    要:目的:研究DNA芯片检测乙型肝炎和肝硬化患者肝组织及血清中乙型肝炎病毒(HBV)DNA的应用价值。方法:用点样仪将聚合酶链反应(PCR)扩增的HBV DNA探针制成基因芯片。对15例慢性乙型肝炎病人的血清和肝活检组织,99例乙型肝炎后肝硬化肝组织,分别用基因芯片、原位分子杂交、免疫组织化学和雅培试剂检测HBV DNA、乙型肝炎核心抗原(HBcAg)、乙型肝炎表面抗原(HBsAg)和乙型肝炎e抗原(HBeAg)。结果:用基因芯片对15份HBsAg,HBeAg阳性的乙型肝炎患者血清进行检测,HBV DNA均阳性,阳性率符合率为100%;15份肝活检组织标本,免疫组化法检测HBcAg阳性15例,原位分子杂交法和基因芯片检测HBV DNA均阳性14例,阳性率93%。99份肝炎后肝硬化患者肝组织标本,HBcAg阳性67份,HBV DNA阳性53份,基因芯片检测HBV DNA阳性46份,阳性率分别为69%、88%。32例HBcAg、HBV DNA阳性的肝组织中,基因芯片检测HBV DNA均为阴性。结论:肝炎基因诊断芯片可检测肝组织及血清中HBV DNA,诊断准确率高,假阳性率低。

关 键 词:DNA芯片  检测  肝组织  血清  乙肝病毒DNA
修稿时间:2002年6月18日

The clinical study on the detecting simultaneity HBV DNA in the serum and liver tissuse of patients with DNA microarry technique
ZHAO Wei ,WAN Jian-min,LIU Wei,ZHANG Lin,LIU Quan-jun,ZHOU Zhen-xian,LIU Xin-jue.The clinical study on the detecting simultaneity HBV DNA in the serum and liver tissuse of patients with DNA microarry technique[J].Chinese Journal of Laboratory Medicine,2003,26(2):79-82.
Authors:ZHAO Wei  WAN Jian-min  LIU Wei  ZHANG Lin  LIU Quan-jun  ZHOU Zhen-xian  LIU Xin-jue
Institution:ZHAO Wei *,WAN Jian-min,LIU Wei,ZHANG Lin,LIU Quan-jun,ZHOU Zhen-xian,LIU Xin-jue. *The Heredity Institute of Nanjing Agriculture University,Nanjing 210003,China
Abstract:Objective To study the application value that the DNA microarryies diagnose hepatitis virus DNA in the serum and liver tissues of patients with hepatitis B and posthepatitic cirrhosis. Methods The DNA microarries were prepared by spotting PCR products labeled fluorescence of the targets genes to the surface of glass slides by the robotics. For HBV DNA?HBcAg?HBsAg and HBeAg in the serum samples and liver tissues of 15 patients with hepatitis B and HBV DNA, HBcAg in the liver tissues of the 99 cases patients with posthepatitic cirrhosis, they were detected and diagnosed by Abbott reagents, immunocytochemistry, by in situ molecule hybridization technique and the gene chips. Results 15 cases serum samples with positive expression of HBsAg and HBeAg diagnosed with Abbott reagents, were all positive diagnosed by the gene chips. For the liver tissues of 15 cases patients, there were 15 cases positive expression of HBcAg and 14 cases positive expression of HBV DNA in liver tissues were positive detected respectively by immunocytochemistry, by in situ molecule hybridization technique and by gene chip. In the 99 liver tissues samples of posthepatitic cirrhosis 67 cases expression of HBcAg, 53 cases expression of HBV DNA were positive detected with immunocytochemistey and with in situ molecule hybridization technique, in which 46 cases expression of HBV DNA were positive detected by gene chip. 32 cases of HBcAg and HBV DNA were negative detected by the three test methods.Conclusion In the serums and liver tissues HBV DNA can be detected simultaneity by the gene chip in diagnosis with great accuracy.
Keywords:Hepatitis B  Liver  DNA Virus  DNA microarrays
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号